People with insomnia often rely on pills to sleep. But what if gentle touch and breathing exercises worked better? A new review looked at Tuina-based combination therapies against oral medication for patients with confirmed insomnia. The group included 2,663 subjects. Researchers compared these therapies to standard oral medication. They measured how well treatments worked and how sleep quality improved. The results showed that Tuina combined with breath guiding, music, foot baths, or acupoint application performed significantly better than taking pills alone. This held true for both the total effective rate and sleep quality scores. Even Tuina with acupuncture or scraping showed improvement over medication. Safety data suggested Tuina with acupoint application had the lowest rate of side events among the options tested. However, the review noted that most evidence quality was low or very low. The network of studies was sparse, which limits definitive safety conclusions. These findings are exploratory and need verification through higher-quality trials. Until then, the potential advantage of these therapies over drug monotherapy remains a promising area for further study.
Tuina combination therapies beat oral medication for insomnia in this exploratory review
Photo by Google DeepMind / Unsplash
What this means for you:
Tuina combination therapies showed potential advantages over oral medication for insomnia in this exploratory review. More on Insomnia
Review synthesizes neuroprotective potential of TCM metabolites using zebrafish models for neurological conditions Traditional Chinese medicine metabolites protect brain cells from damage
Frontiers · May 25, 2026
Meta-analysis of 2,579 participants identifies neural dysfunction patterns in insomnia disorder Insomnia changes brain circuits and gene activity in specific ways
· May 15, 2026
Narrative review links NRXN1 genetic variations to schizophrenia, autism, and other neuropsychiatric disorders New research explains how one gene causes many brain disorders
Frontiers · May 13, 2026
Meta-analysis shows benzodiazepine receptor PAMs improve sleep but increase long-term COPD risks in patients with insomnia New drug improves sleep but raises long-term risks for COPD patients
Frontiers · Apr 29, 2026